Log In
Print
BCIQ
Print
Print this Print this
 

tafenoquine (SB 252263, WR-238605)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionSynthetic analog of primaquine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationMalaria
Indication DetailsPrevent malaria; Treat and prevent relapse of Plasmodium vivax malaria
Regulatory Designation

U.S. - Breakthrough Therapy (Treat and prevent relapse of Plasmodium vivax malaria)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today